Item 5. Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities.
Market Information
Our units, ordinary shares, and warrants are each traded on The Nasdaq Capital Market (“Nasdaq”) under the symbols “MITAU,” “MITA,” and “MITAW,” respectively.
Holders
As of April 14, 2023, we had 1 holder of record of our ordinary shares, 1 holder of record of our units, and 2 holders of record of our warrants.
Dividends
We have not paid any cash dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination will be within the discretion of our board of directors at such time. In addition, our board of directors is not currently contemplating and does not anticipate declaring any share dividends in the foreseeable future. Further, if we incur any indebtedness in connection with our initial business combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.
Securities Authorized for Issuance Under Equity Compensation Plans
None.
Recent Sales of Unregistered Securities; Use of Proceeds from Registered Offerings
Unregistered Sales
On February 17, 2021, the sponsor acquired 4,312,500 shares of Class B ordinary shares (the “founder shares”) for an aggregate purchase price of $25,000, or approximately $0.006 per share. Prior to the initial investment in the company of $25,000 by our founder we had no assets, tangible or intangible. The number of founder shares issued was determined based on the expectation that such founder shares would represent 20% of the outstanding shares after our initial public offering. The founder shares included an aggregate of up to 562,500 Class B ordinary shares subject to forfeiture by the sponsor to the extent that the underwriter’s over-allotment option is not exercised in full or in part, so that the sponsor will own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the initial public offering (assuming the sponsor does not purchase any public shares in the initial public offering). Upon expiration of the over-allotment option on August 6, 2021, 562,500 Class B ordinary shares were forfeited by the sponsor.
Simultaneously with the closing of our initial public offering, we consummated the sale of 3,225,000 warrants at a price of $1.50 per warrant in a private placement (the “private placement warrants”) to our sponsor, generating gross proceeds of $4,837,500. Each private placement warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share. The proceeds from the sale of the private placement warrants were added to the net proceeds from our initial public offering held in a trust account.
Use of Proceeds from the Initial Public Offering
On June 25, 2021, we consummated our initial public offering of 15,000,000 units (the “units” and, with respect to the shares of Class A ordinary shares included in the units sold, the “public shares”), at $10.00 per unit, generating gross proceeds of $150,000,000.
We had granted the underwriter in our initial public offering a 45-day option to purchase up to 2,250,000 additional units to cover over-allotments, if any. In August 2021, the underwriter’s over-allotment option expired.
Simultaneously with the closing of our initial public offering, we consummated the sale of 3,225,000 private placement warrants at a price of $1.50 per warrant, generating gross proceeds of $4,837,500.